Sinusitis clinical trials

Explore recruiting sinusitis clinical trials.

Recruiting sinusitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sinusitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcutaneous human immunoglobulin (Newnorm) in patients with primary immunodeficiency diseases

Italy, Slovakia, Hungary, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

SOPAZITHRO : Evaluation of the Efficacy of 3-month Continuous Extended Treatment With Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults: a Multicentre Randomised Controlled Trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase IV, randomized double blinded placebo-controlled study on the barrier restoring capacity of Dupilumab in type 2 airway disease: CRSwNP

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: the effect on comorbid eosinophilic otitis media

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

PHASE III, OPEN-LABEL, RANDOMIZED, CONTROLLED, NON-INFERIORITY CLINICAL-TRIAL TO ASSESS THE EFFICACY AND SAFETY OF SHORT OUTPATIENT AMOXICILLIN REGIMENS IN CHILDREN WITH ACUTE STREPTOCOCCAL PHARYNGOTONSILLITIS (STOP – TRIAL)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults

Hungary, Belgium, Germany, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sinusitis trials by city

Sinusitis in Toronto Sinusitis in Vancouver Sinusitis in Montreal Sinusitis in Calgary Sinusitis in Edmonton Sinusitis in Ottawa Sinusitis in Winnipeg Sinusitis in Quebec City Sinusitis in Hamilton Sinusitis in Kitchener Sinusitis in London Sinusitis in Halifax Sinusitis in New York Sinusitis in Los Angeles Sinusitis in Chicago Sinusitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease